Particle.news
Download on the App Store
43 ARTICLES
·
4h ago

Trump Announces IVF Drug Price Deal and Voluntary Fertility Benefit for Employers

Analysts say the voluntary approach and discounts on medications address only part of IVF expenses, so the effect on patients’ total costs remains unclear.

President Donald Trump speaks in the Oval Office of the White House, Thursday, Oct. 16, 2025, in Washington. (AP Photo/Alex Brandon)
Image
President Trump shakes hands with Samantha Busch, IVF advocate and wife of Nascar champion Kyle Busch, during an announcement in the Oval Office of the White House in Washington, D.C., on October 16, 2025.
Image

Overview

  • The White House struck a most-favored-nation pricing agreement with EMD Serono to sell Gonal‑F, Ovidrel and Cetrotide at steep discounts on TrumpRx.gov starting in early 2026, with income-based reductions estimated at 42% to 79% and the company citing up to 84% off when all three drugs are used.
  • Labor, Treasury and HHS will issue guidance to let employers offer stand-alone fertility benefits similar to dental or vision coverage, but participation is voluntary and the administration is not mandating coverage or providing subsidies.
  • Officials said the FDA will expedite review of Pergoveris, a fertility medicine already available in Europe, as part of the broader effort to expand treatment options in the U.S.
  • Administration estimates suggest eligible patients could save roughly $1,200 to $1,900 per IVF cycle on medications, with larger discounts available up to 550% of the federal poverty level, though procedures and lab costs remain separate.
  • The package reflects a scaled-back approach compared with President Trump’s 2024 pledge to make IVF free or require insurers to cover it, and prior drug arrangements with Pfizer and AstraZeneca were cited as precedents.